162 related articles for article (PubMed ID: 8102975)
41. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
Payza K; Akar CA; Yang HY
J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.
Lemberg KK; Siiskonen AO; Kontinen VK; Yli-Kauhaluoma JT; Kalso EA
Anesth Analg; 2008 Feb; 106(2):463-70, table of contents. PubMed ID: 18227301
[TBL] [Abstract][Full Text] [Related]
43. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
44. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
Negri L; Noviello L; Noviello V
Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
[TBL] [Abstract][Full Text] [Related]
45. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
46. Calcium channel blockers inhibit the antagonistic effects of Phe-Met-Arg-Phe-amide (FMRFamide) on morphine- and stress-induced analgesia in mice.
Kavaliers M
Brain Res; 1987 Jul; 415(2):380-4. PubMed ID: 2440527
[TBL] [Abstract][Full Text] [Related]
47. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
48. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
[TBL] [Abstract][Full Text] [Related]
49. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
[TBL] [Abstract][Full Text] [Related]
50. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
[TBL] [Abstract][Full Text] [Related]
51. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Nagase H; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2001 Aug; 298(2):592-7. PubMed ID: 11454920
[TBL] [Abstract][Full Text] [Related]
52. Effects of F8Famide analogs on intestinal transit in mice.
Gicquel S; Fioramonti J; Bueno L; Zajac JM
Peptides; 1993; 14(4):749-53. PubMed ID: 8234020
[TBL] [Abstract][Full Text] [Related]
53. Elevation of arterial pressure in rats by two new vertebrate peptides FLFQPQRF-NH2 and AGEGLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum.
Roth BL; Disimone J; Majane EA; Yang HY
Neuropeptides; 1987 Jul; 10(1):37-42. PubMed ID: 3670567
[TBL] [Abstract][Full Text] [Related]
54. Interaction of midazolam and morphine in the spinal cord of the rat.
Yanez A; Sabbe MB; Stevens CW; Yaksh TL
Neuropharmacology; 1990 Apr; 29(4):359-64. PubMed ID: 2160622
[TBL] [Abstract][Full Text] [Related]
55. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
56. Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activity.
Raffa RB
Peptides; 1989; 10(2):403-6. PubMed ID: 2755878
[TBL] [Abstract][Full Text] [Related]
57. Supraspinal and spinal effects of [Phe1psi(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat.
Candeletti S; Guerrini R; Calò G; Romualdi P; Ferri S
Life Sci; 2000; 66(3):257-64. PubMed ID: 10666001
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
[TBL] [Abstract][Full Text] [Related]
59. Involvement of hypogastric and pelvic nerves for conveying cystitis induced nociception in conscious rats.
Meen M; Coudore-Civiale MA; Eschalier A; Boucher M
J Urol; 2001 Jul; 166(1):318-22. PubMed ID: 11435893
[TBL] [Abstract][Full Text] [Related]
60. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
Courteix C; Coudoré-Civiale MA; Privat AM; Zajac JM; Eschalier A; Fialip J
Br J Pharmacol; 1999 Jul; 127(6):1454-62. PubMed ID: 10455296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
